How RINVOQ Works video transcript
Music track throughout.
TEXT ON SCREEN: ULCERATIVE COLITIS
ANNOUNCER VOICE OVER (AVO): Ulcerative colitis,
TEXT ON SCREEN: UC
AVO: also known as UC,
TEXT ON SCREEN: UC
A condition where chronic inflammation damages your colon
AVO: is a condition where chronic inflammation damages your colon,
TEXT ON SCREEN: Sudden accidents
Increased bathroom trips
Blood in your stool
Gut pain
AVO: which can lead to symptoms like sudden accidents, increased trips to the bathroom, blood in your stool, and gut pain.
AVO: You may be used to thinking of inflammation as redness or swelling. When you’re healthy, inflammation is one of your body’s defenses against things that can hurt you or make you sick.
AVO: But, there is such a thing as too much inflammation. That’s the case with UC, where the inner lining of your colon gets inflamed even when your body doesn’t need the protection. Inflammation can build up, causing more damage over time.
TEXT ON SCREEN: WITH UC,
you may be wondering why your immune system doesn’t know when to stop making inflammation.
AVO: With UC, you may be wondering why your immune system doesn’t know when to stop making inflammation. Let’s take a look.
AVO: Your body has many natural pathways involved in inflammation. They pass along information to help your immune system figure out when and where inflammation should happen. One of those pathways involves proteins known as Janus kinase, or JAK proteins.
TEXT ON SCREEN: JAK
AVO: With UC, some JAK proteins receive too many signals, causing your immune system to create too much inflammation and start to damage the colon.
TEXT ON SCREEN:
[RINVOQ logo]
A ONCE-DAILY PILL
RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used and did not work well or could not be tolerated, or after taking a different injection or pill (systemic therapy) when your healthcare provider does not recommend TNF blockers. It is not known if RINVOQ is safe and effective in children with ulcerative colitis.
Please see Important Safety Information in video and on this web page.
Please see link for the full Prescribing Information, including the Medication Guide.
Pill not actual size
AVO: RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used and did not work well or could not be tolerated, or after taking a different injection or pill (systemic therapy) when your healthcare provider does not recommend TNF blockers. It is not known if RINVOQ is safe and effective in children with ulcerative colitis.
TEXT ON SCREEN: JAK
RINVOQ
AVO: RINVOQ stops the activity of some JAK proteins. That means when you have too much inflammation, RINVOQ can help regulate your overactive immune system.
AVO: RINVOQ is a once-daily pill that travels through the bloodstream, helping to reduce inflammation and give your colon lining the chance to repair from the buildup of damage.
TEXT ON SCREEN: IN CLINICAL STUDIES, RINVOQ WAS PROVEN TO HELP DELIVER:
Rapid symptom relief as early as 2 weeks*
*Based on the frequency of bowel movements and the amount of bloody stools.
Remission at 8 weeks, and lasting remission even at 1 year
Visible improvement of the colon lining at 8 weeks and 1 year
AVO: In clinical studies RINVOQ was proven to help deliver rapid symptom relief, lasting remission, and visible improvement of the colon lining.
TEXT ON SCREEN:
[RINVOQ logo]
For adults with moderate to severe ulcerative colitis (UC) in whom TNF blockers did not work well, or after a different injection or pill (systemic therapy) when TNF blockers are not recommended by your healthcare provider
Ask your gastroenterologist if RINVOQ is right for you
US-RNQG-250466
AVO: Ask your gastroenterologist if RINVOQ is right for you.
AVO and TEXT ON SCREEN:
SAFETY CONSIDERATIONS
RINVOQ may cause serious side effects, including:
- Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
- Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
- Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
- Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
- Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
- Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
- Tears in the stomach or intestines; changes in certain laboratory test results.
TEXT ON SCREEN:
Please see additional Important Safety Information and link to Prescribing Information on this page.